LONDON--(BUSINESS WIRE)--Aug 29, 2018--According to the latest market research report released by Technavio, the global cholera vaccines market is expected to accelerate at a CAGR of almost 10% during the forecast period. The lack of proper sanitation and consumption of contaminated food is one of the key factors triggering the growth of the market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180829005515/en/

Technavio has published a new market research report on the global cholera vaccines market from 2018-2022. (Graphic: Business Wire)

This research report titled ‘ ’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. It also includes an up-to-date analysis and forecasts for various market segments and all geographical regions.

This report is available at a USD 1,000 discount for a limited time only:

The market research analysis categorizes the global cholera vaccines market into the following products:

Shanchol DUKORAL Vaxchora

In 2017, the Shanchol segment accounted for 49.67% of the global market and is projected to fall to 49.57% by 2022, exhibiting a slight decrease in market share.

Global cholera vaccines market: Top emerging trend

The increasing number of public-private initiative is an emerging trend in the market. Over the years, there has been a significant increase in the number of public-private partnerships in developing countries. Immunization programs by various governments are effectively backed by several global organizations such as the WHO and the UNICEF and NGOs such as GAVI, which was formerly called the Global Alliance for Vaccines and Immunization. Energy, knowledge, and technical know-how are used in public-private initiatives. All these initiatives are expected to help drive the growth of the global cholera vaccines market and achieve immunization-related global goals.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Technavio’s report provides expert market research on the following topics:

Executive Report

Market Outline Global Cholera Vaccines Market Overview

Market Insights

Market Sizing and Forecasts Market Growth Market Drivers and Challenges Key Emerging Trends

Market Segmentation Analysis

Regional comparison (APAC, Americas, and EMEA) Key leading countries Market segmentation by product (Shanchol, DUKORAL, and Vaxchora)

Vendor Landscape

Vendor classification Market positioning of vendors Competitive scenario Analysis of top vendors (PaxVax, Sanofi, and Valneva)

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180829005515/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 08/29/2018 11:11 AM/DISC: 08/29/2018 11:11 AM

http://www.businesswire.com/news/home/20180829005515/en